Literature DB >> 3718837

Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug.

J Cummings, C S McArdle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3718837      PMCID： PMC2001410          DOI： 10.1038/bjc.1986.141

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  13 in total

1.  Clinical management of advanced gastrointestinal cancer.

Authors:  C G Moertel
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer.

Authors:  R F Ozols; G Y Locker; J H Doroshow; K R Grotzinger; C E Myers; R C Young
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

3.  A fluorometric assay for daunomycin and adriamycin in animal tissues.

Authors:  H S Schwartz
Journal:  Biochem Med       Date:  1973-06

4.  Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study.

Authors:  J A Gottlieb; S E Rivkin; S C Spigel; B Hoogstraten; R M O'Bryan; F C Delaney; A Singhakowinta
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

5.  Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.

Authors:  K Dano
Journal:  Biochim Biophys Acta       Date:  1973-10-25

6.  Comparative pharmacokinetics of daunomycin and adriamycin in several animal species.

Authors:  D W Yesair; E Schwartzbach; D Shuck; E P Denine; M A Asbell
Journal:  Cancer Res       Date:  1972-06       Impact factor: 12.701

7.  Comparative uptake, metabolism and retention of anthracyclines by tumors growing in vitro and in vivo.

Authors:  D W Yesair; P S Thayer; S McNitt; K Teague
Journal:  Eur J Cancer       Date:  1980-07       Impact factor: 9.162

8.  Preliminary pharmacokinetic model for adriamycin (NSC-123127).

Authors:  P A Harris; J F Gross
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

9.  Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS).

Authors:  J Cummings; S Merry; N Willmott
Journal:  Eur J Cancer Clin Oncol       Date:  1986-04

10.  Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model.

Authors:  K K Chan; J L Cohen; J F Gross; K J Himmelstein; J R Bateman; Y Tsu-Lee; A S Marlis
Journal:  Cancer Treat Rep       Date:  1978-08
View more
  26 in total

1.  Preparation and characterization of doxorubicin-loaded sterically stabilized immunoliposomes.

Authors:  N Emanuel; E Kedar; E M Bolotin; N I Smorodinsky; Y Barenholz
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

2.  Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.

Authors:  Muna Aryal; Natalia Vykhodtseva; Yong-Zhi Zhang; Nathan McDannold
Journal:  J Control Release       Date:  2015-02-24       Impact factor: 9.776

Review 3.  Ultrasound for drug and gene delivery to the brain.

Authors:  Kullervo Hynynen
Journal:  Adv Drug Deliv Rev       Date:  2008-04-06       Impact factor: 15.470

4.  Alteration of the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, due to acute gastrointestinal toxicity of doxorubicin.

Authors:  Jing Li; Shufeng Zhou; Hung Huynh; Wei Duan; Eli Chan
Journal:  Pharm Res       Date:  2005-08-13       Impact factor: 4.200

5.  Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery.

Authors:  Ji-Ho Park; Geoffrey von Maltzahn; Luvena L Ong; Andrea Centrone; T Alan Hatton; Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  Adv Mater       Date:  2010-02-23       Impact factor: 30.849

6.  The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.

Authors:  Juyoung Park; Yongzhi Zhang; Natalia Vykhodtseva; Ferenc A Jolesz; Nathan J McDannold
Journal:  J Control Release       Date:  2012-06-15       Impact factor: 9.776

7.  Gold nanorods mediated controlled release of doxorubicin: nano-needles for efficient drug delivery.

Authors:  Sunil Pandey; Ritu Shah; Ashmi Mewada; Mukeshchand Thakur; Goldie Oza; Madhuri Sharon
Journal:  J Mater Sci Mater Med       Date:  2013-03-23       Impact factor: 3.896

8.  Distribution of doxorubicin to normal breast and tumour tissue in patients undergoing mastectomy.

Authors:  S Stallard; J G Morrison; W D George; S B Kaye
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

9.  Antitumor activity of new anthracycline analogues in combination with interferon alfa.

Authors:  M E Berens; T Saito; C E Welander; E J Modest
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Human autopsy-tissue distribution of menogaril and its metabolites.

Authors:  D J Stewart; D Grewaal; R M Green; R Goel; N Mikhael; V A Montpetit; D Redmond; R Earhart
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.